Analytical Documentation
Tirzepatide 20 mg
The values below were transcribed from the analytical report supplied for this listing. They should be matched to the original verification record and applicable inventory lot before commercial publication.
99.807%Reported purity
20.41 mgMeasured amount
#93619Janoshik task
Nominal vial20 mg
Batch shown on reportLight Blue Cap
Analysis conductedDec. 15, 2025
Client shown on reportQSC
Documentation note
Third-party analytical results describe the submitted sample. They do not constitute FDA approval, a medical claim, or a representation that the material is suitable for human or veterinary use.
Third-party analytical results describe the submitted sample. They do not constitute FDA approval, a medical claim, or a representation that the material is suitable for human or veterinary use.